Copyright
©The Author(s) 2015.
World J Orthop. Dec 18, 2015; 6(11): 977-982
Published online Dec 18, 2015. doi: 10.5312/wjo.v6.i11.977
Published online Dec 18, 2015. doi: 10.5312/wjo.v6.i11.977
Table 3 Cost analysis
| Control group(n = 100) | TXA group(n = 100) | Difference | |
| No. of patients transfused | 22 | 2 | 20 |
| No. of units transfused | 55 | 3 | 52 |
| Total cost of transfusion | €11055 | €603 | €10452 |
| BDU | 653 | 547 | 106 |
| Total cost of BDU | €705893 | €591307 | €114586 |
- Citation: McGoldrick NP, O’Connor EM, Davarinos N, Galvin R, Quinlan JF. Cost benefit analysis of the use of tranexamic acid in primary lower limb arthroplasty: A retrospective cohort study. World J Orthop 2015; 6(11): 977-982
- URL: https://www.wjgnet.com/2218-5836/full/v6/i11/977.htm
- DOI: https://dx.doi.org/10.5312/wjo.v6.i11.977